Patents Assigned to IPINTL, LLC
  • NOVEL COMPOSITION
    Publication number: 20110281829
    Abstract: This disclosure relates to a pharmaceutical composition that includes a first agent selected from the group consisting of an oxidative phosphorylation inhibitor, an ionophore, and an adenosine 5?-monophosphate-activated protein kinase (AMPK) activator; a second agent that possesses anti-inflammatory activity; and a third agent that is a serotonin metabolite.
    Type: Application
    Filed: April 27, 2011
    Publication date: November 17, 2011
    Applicant: IPINTL, LLC
    Inventor: Chien-Hung Chen